Orasis Pharmaceuticals
PrivateLast Round
Series D
Oct 8, 2024
Total Funding Raised
$126M
Company Overview
Orasis Pharmaceuticals is a pharmaceutical company that develops and markets ophthalmic solutions, including its FDA-approved prescription eye drop Qlosi for the treatment of presbyopia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orasis Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Orasis Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Oct 8, 2024 | ||||
| Debt | Oct 8, 2024 | ||||
| Series C | Sep 10, 2020 | ||||
| Series B | Jun 5, 2018 |
Key People
Founding team and executive leadership
Orasis Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeSci Venture Partners | Series C, Series B |
| Arboretum Ventures | Series D |
| Maverick Ventures | Series C, Series D |
| Maverick Ventures Israel | Series C |
| SBI JI | Series D, Series B, Series C |
| Catalio Capital Management | Debt, Series D |
| Maverick Ventures | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2024
$68M round led by Johnson & Johnson Innovation and Arboretum Ventures.
- Sep 10, 2020
$30M round led by Bluestem Capital, SBI JI, and Visionary Ventures.
Orasis Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orasis Pharmaceuticals's valuation, stock price, and market status.